Peptide antisense nanoparticles
- PMID: 19004812
- PMCID: PMC2582275
- DOI: 10.1073/pnas.0801609105
Peptide antisense nanoparticles
Abstract
We have designed a heterofunctionalized nanoparticle conjugate consisting of a 13-nm gold nanoparticle (Au NP) containing both antisense oligonucleotides and synthetic peptides. The synthesis of this conjugate is accomplished by mixing thiolated oligonucleotides and cysteine-terminated peptides with gold nanoparticles in the presence of salt, which screens interactions between biomolecules, yielding a densely functionalized nanomaterial. By controlling the stoichiometry of the components in solution, we can control the surface loading of each biomolecule. The conjugates are prepared easily and show perinuclear localization and an enhanced gene regulation activity when tested in a cellular model. This heterofunctionalized structure represents a new strategy for preparing nanomaterials with potential therapeutic applications.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.Bioconjug Chem. 2008 May;19(5):1009-16. doi: 10.1021/bc700421u. Epub 2008 Apr 5. Bioconjug Chem. 2008. PMID: 18393455
-
Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers.Anal Chem. 2007 Mar 15;79(6):2221-9. doi: 10.1021/ac061578f. Epub 2007 Feb 9. Anal Chem. 2007. PMID: 17288407
-
In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles.Nanotechnology. 2010 Dec 17;21(50):505101. doi: 10.1088/0957-4484/21/50/505101. Epub 2010 Nov 22. Nanotechnology. 2010. PMID: 21098932
-
Peptide-functionalized gold nanoparticles: versatile biomaterials for diagnostic and therapeutic applications.Biomater Sci. 2017 May 2;5(5):872-886. doi: 10.1039/c7bm00006e. Biomater Sci. 2017. PMID: 28304023 Review.
-
Targeted lipid nanoparticles for antisense oligonucleotide delivery.Curr Pharm Biotechnol. 2014;15(9):847-55. doi: 10.2174/1389201015666141020155834. Curr Pharm Biotechnol. 2014. PMID: 25335532 Review.
Cited by
-
Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.Bioconjug Chem. 2010 Dec 15;21(12):2250-6. doi: 10.1021/bc1002423. Epub 2010 Nov 11. Bioconjug Chem. 2010. PMID: 21070003 Free PMC article.
-
Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.ACS Nano. 2012 Jan 24;6(1):276-85. doi: 10.1021/nn2035457. Epub 2011 Dec 1. ACS Nano. 2012. PMID: 22117189 Free PMC article.
-
Rational design of gold nanocarrier for the delivery of JAG-1 peptide.J Nanobiotechnology. 2015 Jun 16;13:41. doi: 10.1186/s12951-015-0100-x. J Nanobiotechnology. 2015. PMID: 26077042 Free PMC article.
-
The Polyvalent Gold Nanoparticle Conjugate-Materials Synthesis, Biodiagnostics, and Intracellular Gene Regulation.MRS Bull. 2010 Jul;35(7):532-539. doi: 10.1557/mrs2010.602. Epub 2011 Jan 31. MRS Bull. 2010. PMID: 34539060 Free PMC article.
-
Liposomal Spherical Nucleic Acids for Regulating Long Noncoding RNAs in the Nucleus.Small. 2017 Mar;13(10):10.1002/smll.201602753. doi: 10.1002/smll.201602753. Epub 2016 Dec 27. Small. 2017. PMID: 28026123 Free PMC article.
References
-
- Fire A, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–811. - PubMed
-
- Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature. 1994;372:333–335. - PubMed
-
- Lebedeva I, Stein CA. Antisense oligonucleotides: Promise and reality. Annu Rev Pharmacol Toxicol. 2001;41:403–419. - PubMed
-
- Rosi NL, et al. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science. 2006;312:1027–1030. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous